Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Kaiseron Feb 09, 2022 12:17pm
146 Views
Post# 34412937

RE:RE:RE:RE:Get this approved - now

RE:RE:RE:RE:Get this approved - now

As measures are reduced society will treat covid as a common cold.  Reality is current measures are quite ineffective as numbers continue to rise with lesser side effects.  

Hospital numbers are dropping and icus are not as overwhelmed compared to previous months. I don't see covid simply ending it's definitely here to stay but it appears new variants are weaker than previous.

Ive said this months ago the further this takes to approve the lower of a demand there will be for testing.  If new measures are to simply isolate for 5 days if you have symptoms maybe will do this without getting a test unless required to do so.

As a long term holder I think we may have missed the real growth opportunity.  I still do see an upside when approval news hits but we may be about a year too late.  

I would love to be wrong but the way things are moving doesn't look as promising as it did several months ago.  

Too many delays and missed deadlines has the sp barely holding .40! Strike when the iron is hot Rob. 

Good luck and ignore the bag holders from other covid plays.  The ignore button does wonders.


stockmonster6 wrote: I hope so Moose, but I don't like hearing news of provinces and other areas just 'getting over' it and abandoning PHMs; because over time, if there isn't a concern about Covid, the demand for testing will reduce.

 

<< Previous
Bullboard Posts
Next >>